Skip to main content
. 2020 Oct 15;14(1):100883. doi: 10.1016/j.tranon.2020.100883

Fig. 6.

Fig. 6

Long term immune memory in animals cured with high dose Rova-T or Rova-T + anti-PD1. A) Schematic for KP1 re-challenge study design. At randomization, animals dosed with 0.3 mg/kg high dose Rova-T alone or in combination with anti-PD1 to achieve complete responses. B–D) Tumor volumes for KP1 reinjected into opposite flank of naïve mice or mice cured with Rova-T or Rova-T + ant-PD1 as indicated. Fraction of animals exhibiting measurable regrowth at Day 20 are indicated above graphs.